4.3 Review

Glial calcium and diseases of the nervous system

Journal

CELL CALCIUM
Volume 47, Issue 2, Pages 140-149

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ceca.2009.11.010

Keywords

Glia; Calcium signalling; Astrocytes; Microglia; Neurodegeneration; Psychiatric disorders; Alzheimer's disease; Parkinson's disease; Dementia; Amyotrophic lateral sclerosis

Categories

Funding

  1. Alzheimer's Research Trust (UK) [ART/PG2004A/1]
  2. Grant Agency of the Czech Republic [GACR 309/09/1696, GACR 305/08/1384]
  3. NINDS/NIH
  4. NIH

Ask authors/readers for more resources

The evolution of the central nervous system (CNS) resulted in an appearance of highly specialised neuronal networks optimised for rapid information transfer. In the course of this specialisation neuronal cells lost their metabolic independence and the ability to survive in the absence of homeostatic systems. These homeostatic systems, represented by neuroglia regulate all aspects of CNS function in physiological and pathological conditions. The neurological diseases should be therefore considered as primary gliopathologies, which determine the progression and outcome of neuropathological process. Glial function is intimately regulated by cellular calcium signalling that underlies the specific form of glial calcium excitability. Glial Ca2+ signals are triggered by activation of multiple receptors, and are primarily driven by Ca2+ release from the endoplasmic reticulum. In this review we summarise the role of glial calcium signalling in various forms of pathological processes including neurological and psychiatric disorders and neurodegeneration. (C) 2009 Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available